Towards a druggable epitranscriptome: Compounds that target RNA modifications in cancer BRIT J PHARMACOL
Follow-up of patients with R/R FLT3-mutation-positive AML treated with gilteritinib in the phase 3 ADMIRAL trial BLOOD
MacroH2As regulate enhancer-promoter contacts affecting enhancer activity and sensitivity to inflammatory cytokines CELL REP
Is the Endothelium the Missing Link in the Pathophysiology and Treatment of COVID-19 Complications? CARDIOVASC DRUG THER
Impact of risk scores in outcome of patients with myeloid neoplasms after allogeneic stem cell transplant MED CLIN-BARCELONA
An endothelial proinflammatory phenotype precedes the development of the engraftment syndrome after autologous Hct BONE MARROW TRANSPL
Self-assembling protein nanocarrier for selective delivery of cytotoxic polypeptides to CXCR4(+) head and neck squamous cell carcinoma tumors ACTA PHARM SIN B